Patenti Un Preču Zīmes

Total Page:16

File Type:pdf, Size:1020Kb

Patenti Un Preču Zīmes PATENTI unPATENTI pre‡u zÏmes LATVIJAS REPUBLIKAS PATENTU VALDES OFICI¬LAIS V»STNESIS 5 / 2011 The Official Gazette of the Patent Office of the Republic of Latvia - "Patenti un preču zīmes" - contains recordings in the Registers of Inventions, Trademarks and Service marks, Industrial designs and Topographies of Semiconductor Products. Date of publication of the registered inventions, trademarks and industrial designs - May 20, 2011. Latvijas Republikas Patentu valde Patent Office of the Republic of Latvia Citadeles iela 7/70, Rīga, LV - 1010 7/70 Citadeles iela, Rīga, LV - 1010 a/k 824, Rīga, LV - 1010 P.O. Box 824, Rīga, LV - 1010 LATVIJA LATVIA Tālruņi: 67 099 600 Phones: 371 67 099 600 67 099 621 371 67 099 621 67 099 618 371 67 099 618 Fakss: 67 099 650 Fax: 371 67 099 650 E-pasts: [email protected] E-mail: [email protected] Mājaslapa: http://www.lrpv.lv Website: http://www.lrpv.lv © Latvijas Republikas Patentu valde, 2011 ISSN 1691-5968 PATENTI un PREČU ZĪMES LATVIJAS REPUBLIKAS PATENTU VALDES OFICIĀLAIS VĒSTNESIS Latvijas Republikas Patentu valde, Rīga, Citadeles ielā 7/70 Pasta adrese: a/k 824, Rīga, LV-1010, Latvija 5/2011 Tālrunis 67 099 618 Fakss 67 099 650 20.maijs 627. - 802. lappuse S A T U R S C O N T E N T S INFORMĀCIJA INFORMATION Hronika ................................................................. 629 Activities of LPO .................................................. 629 Informācija par Patentu valdes Apelācijas Information on the Decisions of the Board of padomes lēmumiem ............................................ 631 Appeal of LPO ..................................................... 631 IZGUDROJUMI INVENTIONS Izgudrojumu pieteikumu publikācijas ................... 644 Publication of Patent Applications ....................... 644 Izgudrojumu patentu publikācijas .......................... 654 Publication of Invention Patents .......................... 654 Attiecināto Eiropas patentu pieteikumu Publication of Extended European Patent publikācijas ........................................................... 665 Applications .......................................................... 665 Attiecināto Eiropas patentu publikācijas Publication of Extended European Patents (LR Patentu likuma 19. panta 2. un 4. daļa) ..... 670 (Patent Law, Article 19, Paragraphs 2 and 4) ... 670 Latvijā apstiprināto Eiropas patentu Publication of European Patents Validated in publikācijas ........................................................... 678 Latvia .................................................................... 678 Patentu ierobežošana .......................................... 757 Patent Limitation ................................................... 757 Papildu aizsardzības sertifikāti ............................ 759 Supplementary Protection Certificates ................ 759 Pieteicēju, izgudrotāju un īpašnieku Name Index of Applicants, Inventors and alfabētiskais rādītājs ............................................ 760 Owners ................................................................. 760 Izgudrojumu pieteikumu un patentu Application and Patent Number Index numuru rādītājs .................................................... 762 of Inventions ........................................................ 762 PREČU ZĪMES TRADEMARKS Reģistrētās preču zīmes ...................................... 763 Registered Trademarks ....................................... 763 Preču zīmju pieteikumu numerācijas rādītājs ..... 780 Application Number Index of Trademarks .......... 780 Preču zīmju īpašnieku rādītājs ............................ 781 Name Index of Trademark Owners ..................... 781 Preču zīmju rādītājs pēc preču un Trademark Registrations Listed by Classes of pakalpojumu klasēm ......................................... 782 Goods and Services ............................................ 782 DIZAINPARAUGI INDUSTRIAL DESIGNS Reģistrētie dizainparaugi ................................... 783 Registered Industrial Designs ............................. 783 GROZĪJUMI VALSTS REĢISTROS CHANGES IN THE STATE REGISTERS Grozījumi Patentu reģistrā ................................... 788 Changes in the Patent Register .......................... 788 Grozījumi Valsts dizainparaugu reģistrā ............. 788 Changes in the Industrial Designs Register ...... 788 Grozījumi Valsts preču zīmju reģistrā ................. 789 Changes in the Trademarks Register ................. 789 Grozījumi Patentpilnvaroto reģistrā ..................... 794 Changes in the Register of Patent Attorneys .... 794 Pamanīto kļūdu labojums .................................... 795 Correction of Mistakes ........................................ 795 Patentpilnvaroto saraksts ..................................... 796 List of Patent Attorneys ........................................ 796 Informācija PATENTI UN PREČU ZĪMES - 20.05.2011 Hronika Laikā no 12. līdz 13. aprīlim Patentu valdes direk- sākot no 2006. gada janvāra, atsevišķās sadaļās ir tora pienākumu izpildītāja Jekaterina Macuka, direktora mainīta jau vairākkārt (2007. gada janvārī un oktobrī, vietnieks rūpnieciskā īpašuma jautājumos, Izgudrojumu 2008. gada janvārī un aprīlī, 2009. gada janvārī un ekspertīzes departamenta direktors Guntis Ramāns un 2010. gada janvārī). Preču zīmju un dizainparaugu departamenta direktore Dace Liberte Viļņā (Lietuva) piedalījās Lietuvas Patentu ∗∗∗ biroja un Pasaules Intelektuālā īpašuma organizācijas kopīgi rīkotajā starptautiskajā konferencē „Rūpniecis- No 2. līdz 4. maijam Patentu valdes Preču zīmju kais īpašums konkurētspējas nodrošināšanai: ES un un dizainparaugu departamenta direktore Dace Liberte globālā pieredze”. un šī departamenta Nacionālo zīmju nodaļas vadītāja Konferencē kā lektori uzstājās gan Pasaules Baiba Graube Alikantē (Spānija) piedalījās Iekšējā Intelektuālā īpašuma organizācijas pārstāvji - ģene- tirgus saskaņošanas biroja (preču zīmes un dizain- rāldirektora vietnieks J. Kristians Vihards (J.Christian paraugi) (turpmāk - ITSB) Administratīvās padomes Wichard), Atsevišķu Eiropas un Āzijas valstu noda- un Budžeta komitejas sanāksmēs. ļas konsultante Li Maora (Li Maor) un Madrides un Kopš 2004. gada sākuma ITSB Apelācijas pa- Lisabonas starptautisko reģistru darbības dienesta domju locekļus apstiprina ITSB Administratīvā padome. vadītāja Austa Valdimarsdotira (Ásta Valdimarsdóttir), Nākošgad beigsies pilnvaru termiņš trijiem Apelācijas gan Eiropas Patentu iestādes pārstāvji - prezidents padomes locekļiem, tādēļ Administratīvā padome iz- Benuā Batistelli (Benoît Battistelli) un viceprezident veidoja atlases komiteju un apstiprināja sludinājuma Raimunds Lucs (Raimund Lutz), gan Iekšējā tirgus tekstu šīm vakantajām vietām. saskaņošanas biroja (preču zīmes un dizainparaugi) pārstāvis Vinsents O’Reilijs (Vincent O’Reilly). Infor- ITSB pārstāvji Administratīvo padomi informēja māciju par Lietuvas aktualitātēm intelektuālā īpašuma par iestādes 2010. gada darbības rezultātiem, kā aizsardzības jomā sniedza gan Lietuvas Patentu bi- arī par galvenajām aktivitātēm 2011. gada pirmajā roja pārstāvji, gan patentpilnvarotie, gan Kultūras un ceturksnī - preču zīmju un dizainparaugu pieteikumu Ekonomikas ministriju darbinieki, gan arī rūpniecības, un reģistrāciju skaitu un laiku, kas pašreiz paiet no zinātnes un izglītības iestāžu pārstāvji. Pasaules In- preču zīmes vai dizainparauga pieteikuma saņemša- telektuālā īpašuma organizācijas pārstāvji pasniedza nas dienas līdz reģistrācijas brīdim. Informācija tika balvas labākajiem jaunajiem Lietuvas izgudrotājiem. sniegta arī par Apelācijas padomju darbību, e-biznesa programmu, par ITSB sadarbības programmām ar Konferences laikā notika kārtējā Ziemeļvalstu un dalībvalstu preču zīmju un dizainparaugu iestādēm un Baltijas valstu rūpnieciskā īpašuma iestāžu vadītāju kopīgajiem projektiem informācijas tehnoloģiju jomā. sanāksme, un Lietuvas Patentu birojs atzīmēja arī savu 20. dzimšanas dienu. Eiropas Komisijas pārstāve Margota Frēlingere (Margot Fröhlinger) Administratīvo padomi informēja par sagaidāmajiem priekšlikumiem likumdošanas ∗∗∗ jomā. 2011. gada martā tika publicēts Maksa Planka Intelektuālā īpašuma un konkurences tiesību institūta 13. aprīlī Patentu valdes Izgudrojumu ekspertī- sagatavotais pētījums par Eiropas preču zīmju sistē- zes departamenta vadošais eksperts fizikāli tehnisko mas funkcionēšanu. Paredzams, ka Eiropas Komisija izgudrojumu jautājumos Jānis Ratenieks piedalījās ar konkrētiem likumdošanas priekšlikumiem, kas va- Eiropas Patentu iestādes organizētajā informatīvajā rētu attiekties gan uz Kopienas preču zīmju regulu sanāksmē, kas galvenokārt bija veltīta jaunas patentu (207/2009), gan uz Preču zīmju direktīvu (2008/95/EK), klasifikācijas sistēmas izstrādei un ieviešanai praksē nāks klajā š.g. oktobrī. jau no 2013. gada. Šī patentu klasifikācijas sistēma tiek dēvēta par Kooperatīvo patentu klasifikāciju Spānijas rūpnieciskā īpašuma iestādes pārstā- (Cooperative Patent Classification, CPC) un integrē vis Administratīvās padomes locekļus iepazīstināja līdz šim separāti vai paralēli izmantotās trīs patentu ar savas iestādes „labāko praksi”, proti, ar Spānijas klasifikācijas sistēmas: starptautisko (IPC), Eiropas valdības izstrādāto rūpnieciskā īpašuma stimulēšanas (ECLA) un ASV (USPTO). Kaut arī Latvijas Paten- plānu 2010. - 2012. gadam un tā pirmajiem provizo- tu valde nepiedalās CPC izstrādē tieši, jau šobrīd riskajiem rezultātiem. ir jāsāk gatavoties tās ieviešanai praksē, domājot ITSB prezidents Antonio Kampinoss (Antonio ne tikai par ekspertu kvalifikācijas uzlabošanu, bet Campinos) Administratīvo
Recommended publications
  • PCT Gazette, Weekly Issue No. 29, 1998
    29/1998 23 Jul/juil 1998 PCT Gazette - Section I - Gazette du PCT 11497 SECTION I PUBLISHED INTERNATIONAL APPLICATIONS DEMANDES INTERNATIONALES PUBLIÉES 6 (11) WO 98/31208 (13) A1 (43) 23 Jul/juil 1998 (23.07.1998) (51) A01J 7/00 // 5/017, A01K 1/12, H05K 5/00 (51)6 A01C 5/06 (21) PCT/GB98/00026 (54) A DEVICE FOR A MILKING STALL DISPOSITIF DESTINE A UNE SALLE DE (54) PLANTING UNIT TRAITE (22) 14 Jan/jan 1998 (14.01.1998) UNITE DE PLANTATION (25) en (26) en (71) ALFA LAVAL AGRI AB [SE/SE]; P.O. Box 39, (71, 72) BAUGHER, Roger, D. [US/US]; P.O. Box S–147 21 Tumba (SE). 79–A, McClure, IL 62957 (US). BAUGHER, Gar- (for all designated States except / pour tous les États (31) 9700754.6 (32) 15 Jan/jan 1997 (33) GB reth, D. [US/US]; P.O. Box 79–A, McClure, IL désignés sauf US) (15.01.1997) 62957 (US). (72, 75) KULLBERG, Marianne, Kristina, (43) 23 Jul/juil 1998 (23.07.1998) (74) MATTHEWS, Stephen, R.; Haverstock, Garrett & Åkesdotter [SE/SE]; Östmarksgatan 36, S–123 6 Roberts, Suite 1610, 611 Olive Street, St. Louis, 42 Farsta (SE). GUSTAFSON, Percy, Birger, (51) A01B 35/24 MO 63101 (US). Kenneth [SE/SE]; Björknäsvägen 25, S–151 37 Södertälje (SE). (54) TINE FOR MOUNTING ON SOIL–WORKING (81) AL AM AT AU AZ BA BB BG BR BY CA CH IMPLEMENT CN CU CZ DE DK EE ES FI GB GE GH HU IL (74) BERGLUND, Stefan et al. / etc.; Bjerkéns DENT S’ADAPTANT SUR UN ENGIN DE TRA- IS JP KE KG KP KR KZ LC LK LR LS LT LU Patentbyrå KB, Östermalmsgatan 58, S–114 50 VAIL DU SOL LV MD MG MK MN MW MX NO NZ PL PT RO Stockholm (SE).
    [Show full text]
  • Abstract Book 2014.Indd
    JOURNAL OF PSYCHOPHARMACOLOGY SUPPLEMENT TO VOLUME 28, ISSUE 8, AUGUST 2014 These papers were presented at the Summer Meeting of the BRITISH ASSOCIATION FOR PSYCHOPHARMACOLOGY 20 – 23 July, Cambridge, UK Indemnity The scientific material presented at this meeting reflects the opinions of the contributing authors and speakers. The British Association for Psychopharmacology accepts no responsibility for the contents of the verbal or any published proceedings of this meeting. All contributors completed a Declaration of Interests form when submitting their abstract BAP Office 36 Cambridge Place Hills Road Cambridge CB2 1NS www.bap.org.uk Aii CONTENTS Abstract Book 2014 Abstracts begin on page: SYMPOSIUM 1 Psycho-immunology (S01-S04) A1 SYMPOSIUM 2 Predictors of clinical response in depression (S05-S08) A2 SYMPOSIUM 3 ADHD and obesity: Overlapping neurobiology and development of pharmacological treatments (S09-S12) A3 SYMPOSIUM 4 Cannabinoids in psychiatry: Current understanding and future treatments (S13-S16) A4 SYMPOSIUM 5 Chickens and Eggs: Separating cause and effect in drug addiction (S17-S20) A6 SYMPOSIUM 6 Genetic pathways in psychosis: the road to new treatments? (S21-S24) A7 SYMPOSIUM 7 The adolescent brain – A key stage in the development of psychiatric disorders? (S25-S28) A8 SYMPOSIUM 8 Tobacco addiction in schizophrenia: a translational investigation (S29-S32) A9 SYMPOSIUM 9 Dopamine, impulse control disorders and Parkinson’s disease (S33-S36) A11 POSTERS Cognition (Animals) (MA01-MA14) A12 Drug Dependence (Human) (MB01-MB28)
    [Show full text]
  • The Joint Pharmacokinetics UK 2005 and Rosenön Meeting
    Welcome to the joint Pharmacokinetics UK 2005 and Rosenön Meeting Wednesday 23rd – Friday 25th November, 2005 De Vere Grand Hotel King’s Road Brighton BN1 2FW Programme and Abstract Book Published with the support of John Wiley & Sons Ltd, publishers of the journal BIOPHARMACEUTICS AND DRUG DISPOSITION rd Wednesday 23 November 12.30 Arrival, Coffee & Buffet Welcome & Session 1: Pharmacogenetics on PK/PD 13:50 Welcome (Steve Toon & Amin Rostami) 14:00 Introduction to the First Session: Geoff Tucker and Margareta Hammarlund-Udenaes 14:05 Geoff Tucker Pharmacogenetics on PKPD – expectations and reality 14:35 Duncan McHale Applications of Pharmacogenomics to the drug discovery and development pipeline 15:05 Leif Bertilsson Interethnic differences in drug disposition 15.30 Coffee break Viewing Posters & Exhibitions 16:00 Munir Pirmohamed Pharmacogenetics of adverse drug reactions Simulations as a tool to assess the propagation of genetic polymorphisms in drug Gemma Dickinson 16:20 metabolising enzymes into PK and PD outcomes 16:40 Marja-Liisa Dahl Pharmacogenetics in PK and PD of warfarin 17:30 Break 18:30 Poster Session – Free Bar 20:30 Dinner th Thursday 24 November Session 2: Microdosing in Drug Development 09:00 Introduction to Second Session: Anders Grahnen and Steve Toon 09:10 Colin Garner Human PK studies on microdoses of drugs - scientific and regulatory perspectives Seeing through the MIST: abundance versus percentage commentary on metabolites 09:50 Dennis Smith safety testing 10:30 Coffee break Viewing Posters & Exhibitions 11:00
    [Show full text]
  • 2017 MEDIA KIT “In One Word EXTRAORDINARY
    PRINT • ONLINE • EMAIL DELIVERED • LIVE EVENT Providing broad coverage and incisive analysis of the issues, events, trends The Magazine of Pharmaceutical Business and Marketing • medadnews.com • October 2016 • Volume 35, Number 5 • $100 and strategies shaping pharmaceutical TOP 50 PHARMACEUTICAL COMPANIES business, marketing and sales returns with a robust 2017 lineup designed to meet the needs of our pharmaceutical The Magazine of Pharmaceutical Business and Marketing • medadnews.com • February 2016 • Volume 35, Number 1 • $25 inside agenda2016 specialfeature top10pipelines specialfeature By Andrew Humphreys • [email protected] cation was supported by data from the TURQUOISE-III TOP 10 PIPELINES trial, which demonstrated 100 percent sustained viro- Top 10 Pipelines logic response at 12 weeks AbbVie post-treatment (SVR12) in this patient population. Amgen The pharma industry’s R&D concentration has been shifting towards specialty In early December 2015, AstraZeneca AbbVie announced that FDA therapy areas as research and development returns decline for some leaders. accepted the company’s NDA Biogen for a once-daily, fixed-dosed Gilead ith the average cost of getting a novel medi- overall response rate as monotherapy treatment, including pa- version of Viekira Pak to treat By Joshua Slatko • [email protected] cine to the marketplace at nearly $2.5 billion, tients that achieved complete remission. GT1 HCV. The proposed dos- Merck it is more crucial than ever for drug compa- Three FDA Breakthrough Therapy Designations have been ing for the fixed-dose form is Novartis W nies to succeed in their R&D efforts. However, granted by FDA for venetoclax. The first designation was re- three oral tablets, taken once according to a recent study generated by De- ceived in early 2015 for treating patients with R/R CLL with per day with a meal, with or Roche loitte in collaboration with the research and consulting firm chromosome 17p deletion.
    [Show full text]
  • Гласник Интелектуалне Својине Intellectual Property Gazette 2020/8
    Гласник интелектуалне својине Intellectual Property gazette 2020/8 Београд / Belgrade 2020/8 НАСЛОВНА СТРАНА / Title page НАСЛОВНА СТРАНА / Title page ГЛАСНИК ИНТЕЛЕКТУАЛНЕ СВОЈИНЕ INTELLECTUAL PROPERTY GAZETTE P 60471 - 60615 Датум Година ГЛАСНИК U 1660 - 1663 објављивања: ИНТЕЛЕКТУАЛНЕ излажења 2020 број 8 СВОЈИНЕ Ж 78953 - 78967 31.08.2020. C Д 11451 - 11460 Београд Издаје и штампа: Завод за интелектуалну својину, Београд, Кнегиње Љубице 5, Београд, Србија Телефони: 011 20 25 800 (централа); факс: 011 311 23 77 Е-mail: [email protected] www.zis.gov.rs Гласник интелектуалне својине 2020/8 Intellectual Property Gazette 2020/8 САДРЖАЈ / Contents ПАТЕНТИ / Patents ....................................................................................................................................................... 6 ОБЈАВА ПРИЈАВА ПАТЕНАТА / Publication of Patent Applications .................................................................. 8 ПОСЕБНА ОБЈАВА ИЗВЕШТАЈА О СТАЊУ ТЕХНИКЕ А3 / Separate publication of search report A3 ....... 17 ОБЈАВА УПИСАНИХ ПРОМЕНА У ПРИЈАВАМА ПАТЕНАТА / Publications of Entered Changes in Patent Applications ............................................................................................................................................... 18 РЕГИСТРОВАНИ ПАТЕНТИ / Patents granted .................................................................................................... 19 OБЈАВА ПАТЕНАТА У ИЗМЕЊЕНОМ ОБЛИКУ / PUBLICATION OF THE AMENDED PATENTS ..... 52 ИСПРАВЉЕН СПИС B ДОКУМЕНТА / COMPLETE
    [Show full text]
  • 2 FG9A Nationale Patente Brevets Nationaux Brevetti Nazionali
    31.8.2001 CH PMMBI/FBDM/FBDM 16 2 FG9A 1253 Vandoeuvres (CH) D-89520 Heidenheim (Brenz) (DE) N Agneta Riviera-Boklund N Luber, Joachim Nationale Patente 6, chemin de la Lulasse Dewanger Strasse 19 1253 Vandoeuvres (CH) D-73457 Essingen-Forst (DE) Brevets nationaux P Cabinet Roland Nithardt Conseils en Mackevics, Arvids Propriété Industrielle S.A. Deutschordenstrasse 55 Brevetti nazionali Y-PARC Chemin de la Sallaz D-73432 Aalen-Waldhausen (DE) Case postale 3347 Ulrich Lemcke 1400 Yverdon (CH) Oggenhauser Hauptstrasse 32 89522 Heidenheim (DE) I A 47 L 013/258 2.3 FG3A A Hartmut Gärtner 691 566 Jenaer Strasse 19 B 03398/95 73447 Oberkochen (DE) Ohne Vorprüfung erteilte C 30.11.1995 Christian Duschek Patente F 26.01.1995 IT VE95U000003 Brackwanger Strasse 42 K Scopa ad umido del tipo a redazza. 73572 Heuchlingen (DE) Brevets délivrés sans O examen préalable Euromop S.p.A. P Dennemeyer AG Via G. Verdi 2/B5 Schulhausstrasse 12 Brevetti rilasciati senza Cittadella (Padova) (IT) 8002 Zürich (CH) N Sergio Cervellin esame preventivo via dell’Artigianato I A 61 C 013/30 35010 Villa del Conte (IT) A 691 570 P ABREMA Agence Brevets & Marques B 02054/96 I A 01 G 017/06 Ganguillet & Humphrey C 21.08.1996 A 691 562 5, rue Centrale K Tenon dentaire et pièce d’armature B 02476/96 1003 Lausanne (CH) utilisée pour ce tenon. C 10.10.1996 O Maillefer Instruments S.A. I Z F 19.10.1995 DE 195 39 019.9 A 61 B 003/12 G 01 B 009/02 1338 Ballaigues (CH) A K Haltevorrichtung für ein oder 691 624 N François Aeby mehrere Tragelemente und I A 61 B 005/107, A 61 F 002/46, chemin des Haies Einrichtung, in in welcher mehrere G 01 B 003/46 1442 Montagny-près-Yverdon (CH) solcher Haltevorrichtungen A 691 567 P Jean S.
    [Show full text]
  • USE of ELECTRONIC PATIENT RECORDS for RESEARCH and HEALTH BENEFIT 24–25 May 2007
    FRONTIERS MEETING USE OF ELECTRONIC PATIENT RECORDS FOR RESEARCH AND HEALTH BENEFIT 24–25 May 2007 UK Clinical Research Collaboration and the Wellcome Trust Frontiers meeting on the use of electronic patient records for research and health benefit 24 and 25 May 2007 at the Wellcome Trust Conference Centre, London, UK 1 UK Clinical Research Collaboration–Wellcome Trust Use of Electronic Patient Records for Research and Health Benefit Contents UK Clinical Research Collaboration and the Wellcome Trust................................................ 1 Contents .................................................................................................................................. 2 Introduction.............................................................................................................................. 3 Report of the meeting.............................................................................................................. 5 Appendix 1: Agenda of the meeting...................................................................................... 12 Appendix 2: Speaker biographies......................................................................................... 15 Appendix 3: Synopses of presentations ............................................................................... 23 Session 1: The vision and the benefits..................................................................................................... 23 Session 2: Use of electronic patient records in the USA........................................................................
    [Show full text]
  • Stages Presso Aziende Europee
    PROGETTO LEONARDO UNIROMA-PHARMA-TRAINING - GUIDA PER I CANDIDATI (versione del 23-9-03) 1 352*5$00$/(21$5'2'$9,1&, STAGES PRESSO AZIENDE EUROPEE 352*(77281,520$3+$50$75$,1,1* *8,'$3(5,&$1','$7, 6&$'(1=$ WLURFLQLGLVHLPHVLSHUJOLVWXGHQWLGHOOH)DFROWjGL)DUPDFLD6FLHQ]HH0HGLFLQD ODXUHHLQ )DUPDFLD&KLPLFDH7HFQRORJLD)DUPDFHXWLFKH&KLPLFD&KLPLFD,QGXVWULDOH6FLHQ]H %LRORJLFKH0HGLFLQDH&KLUXUJLD HFRUULVSRQGHQWLODXUHHVSHFLDOLVWLFKH H%LRWHFQRORJLH VRORODXUHHVSHFLDOLVWLFKH / DPPRQWDUHGHLFRQWULEXWLqGLFLUFD¼DOPHVHÊLQROWUHSUHYLVWRXQFRQWULEXWRIRUIHWWDULR SHUOHVSHVHGLYLDJJLRGRFXPHQWDWHILQRDXQPDVVLPRGL¼ ,OEDQGRqGLVSRQLELOHSUHVVR ZZZXQLURPDLWLQWHUQD]LRQDOHHXURSDSURJOHRQDUGRGHIDXOWKWP PROGETTO LEONARDO UNIROMA-PHARMA-TRAINING - GUIDA PER I CANDIDATI (versione del 23-9-03) 2 6200$5,2 IL BANDO .....................................................................................................................................3 LE DESTINAZIONI .......................................................................................................................7 REGNO UNITO..........................................................................................................................7 ELI LILLY..............................................................................................................................7 GLAXOSMITHKLINE ...........................................................................................................8 MERCK SHARP & DOHME..................................................................................................9
    [Show full text]
  • Friday, September 16, 2016
    Friday, September 16, 2016 FRIDAY,SEPTEMBER 16, 2016 DAY-AT-A-GLANCE Time/Event/Location All locations in the Georgia World Congress Center unless otherwise noted 6:00 am - 8:00 am . .. .. .. .. .. ................................................................... 3 ASBMR Clinical Breakfast: How Discoveries Lead to Treatment of Rare Bone Diseases Room A302 7:00 am - 7:00 pm . .. .. .. .. .. ................................................................... 3 ASBMR Registration Open Registration Hall - Main Entrance 8:00 am - 9:30 am . .. .. .. .. .. ................................................................... 3 Gerald D. Aurbach Lecture and the Presentation of the William F. Neuman and Friday Lawrence G. Raisz Awards Thomas B. Murphy Ballroom - Building B Level 5 9:30 am - 10:00 am . .. .. .. .. .. ................................................................... 3 Networking Break Murphy Ballroom Foyer - Building B 10:00 am - 11:30 am.. .. .. .. .. ................................................................... 4 Highlights of the ASBMR 2016 Annual Meeting Thomas B. Murphy Ballroom - Building B Level 5 10:00 am - 11:30 am.. .. .. .. .. ................................................................... 4 Grant Writing Workshop: What to Choose and How to Fund It Room A302 10:45 am - 11:45 am.. .. .. .. .. ................................................................... 4 Meet-The-Professor Sessions Rooms A311-316 11:30 am - 12:00 pm . .. .. .. .. ................................................................... 5 Networking
    [Show full text]
  • Client List LATEST
    Client number client name country area code client comments corporate number 1382 3 FHEA LAB AD GER SONER C11612 1017 3M MEDICAL DEPARTMENT USA ST PAUL 785 A.H. MARNE & CO LTD UK BRADFORD C11634 1781 ART JAPAN INC. JAP TOKYO 103 Applied Ananlytical Immagary Inc. 644 ABBOTT LABORATORIES LTD US ilILLINOIS Abbott Park C10042 1789 ACTIVE BIOTECH RESEARCH SWE LUND Lund Research Centre AB 1244 AGAN CHEMICAL ITA C10693 1245 AGOURON PHARMACEUTICALS INC. USA SAN DIEGO C10007 774 AGREVO UK LTD UK Now use 1849 Aventis CropScience 1302 AGRITECH UK LIMITED UK SELBOURNE C11646 619 AGRO KAHEAHO COMPANY LTD JAP TOKYO C10854 1773 AIR PRODUCTS AND CHEMICALS INC USA USA C10007 702 AJIMOMOTO CO INC JAP C10323 1946 AJIMOMOTO PHARMACEUTICALS EURO UK REDHILL EUROPE LTD 1043 AKED INTERVET NET C10211 1710 AKZO NOBEL SWE STENLUNGEUN C10210 254 ALBRIGHT & WILSON UK LIMITED UK HENLEY C11661 ALEEN LABORATORIES INC USA FORT WORTH C10663 1747 ALIZYME THERAPEUTICSLTD UK CAMBRIDGE C14475 ALLELEX BIO PHARMACEUTICALS CAN ONTARIO C14103 804 ALLERMAN UK C10903 2791 ALLERCENE LTD RAMAT ISRAEL 1725 ALLERGY THERAPEUTICS LTD UK WORTHING 635 ALMIRALL SPA BARCELONA C10320 1741 ALPHARMA AU NOR OSLO C23276 628 AMERICAN CYANAMID COMPANY USA C10016 1838 AMRAD OPERATIONS PTY LTD AUS RICHMOND C10135 1702 AMVAC CHEMICAL CORPORATIONUSA USA CITY OF CO City of COMMERCE, California C10814 1184 AMYLIN EUROPE LTD UK OXFORD C10020 1070 ANCARE NEW ZEALAND LTD NZ AUCKLAND 607 ANT. INTERNATIONAL LTD UK SUDBURY C11694 1622 ANTISEPTICA GmbH GER 1070 AORTECH EUROPE LTD UK LEEDS 1098 APHTON CORPORATION USA WOODLAND CITY C10916 1737 APOTEX RESEARCH INC. CAN ONTARIO C14502 1628 AQUAMARINE (LONDON) LTD UK HOUNSLOW 1711 ARIAD PHARMACEUTICALS INC USA MASS.
    [Show full text]
  • Pat 0.Vp:Corelventura
    Lietuvos Respublikos valstybinio patentø biuro oficialiame biuletenyje skelbiami iðradimai, dizainas, prekiø þenklai, registruoti Lietuvos Respublikos registruose pagal 2000 m. spalio 10 d. Lietuvos Respublikos prekiø þenklø ástatymà Nr. VIII-1981, 1994 m. sausio 18 d. Lietuvos Respublikos patentø ástatymà Nr. I-372, 2002 m. lapkrièio 7 d. Lietuvos Respublikos dizaino ástatymà Nr. IX–1181, Europos patentinës paraiðkos bei patentai, iðplësti Lietuvos Respublikoje 1994 m. sausio 25 d. Lietuvos Respublikos Vyriausybës ir Europos Patentø organizacijos (EPO) susitarimu dël Europos patentø galiojimo iðplëtimo, bei Europos patentinës paraiðkos, paduotos pagal Europos patentø konvencijà (EPK), kurioms suteikta laikina apsauga Lietuvos Respublikoje ir Europos patentai, ásigaliojæ Lietuvos Respublikoje pagal EPK. Iðradimø, dizaino, prekiø þenklø bei Europos patentiniø paraiðkø bei patentø paskelbimo ðiame oficialaus biuletenio numeryje data - 2006 m. rugpjûèio 25 d. The Official Gazette of the State Patent Bureau of the Republic of Lithuania contains recordings in the Registers of Patents, Designs, Trademarks of the Respublic of Lithuania under the Law on Trademarks of the Republic of Lithuania No. VIII-1981 of October 10, 2000, the Patent Law of the Republic of Lithuania No. I-372 of January 18, 1994, the Design Law of the Republic of Lithuania No. IX–1181 of November 7, 2002, data on European Patent Applications and Patents extended to Republic of Lithuania under the Agreement on the extension of European Patents between the Government of the Republic of Lithuania and the European Patent Organization (EPO) of January 25, 1994, and European Patent Applications filed under European Patent Convention (EPC), that have provisional protection in Republic of Lithuania, and Europian Patents granted in Republic of Lithuania according to EPC.
    [Show full text]
  • Actavis Group V. Eli Lilly: Cross-Border Infringement Jurisdiction
    Actavis Group v. Eli Lilly: Cross-Border Infringement Jurisdiction Earlier this week in Actavis Group HF v. Eli Lilly & Co., [2012] EWHC 3316 (Pat)(High Court 2012)(Arnold, J.), a trial court has ruled that the home British tribunal French, German, Italian and Spanish infringement (together with British infringement). Progressive Attitude of the British Judiciary: The Court was “unimpressed by the [patentee’s] argument that foreign law is difficult and expensive to prove because it is treated as a question of fact. Nowadays, it is increasingly common for English courts to follow the approach [exemplified by] by Laddie J in Celltech R & D Ltd v MedImmune Inc [2004] EWHC 1124 (Pat)…. Furthermore, it is increasingly common in intellectual property cases for the courts of this country to apply case law from other EU Member States when deciding questions of European Union law or national law based on European conventions such as the CPC[.]” Id. at ¶ 99. The Federal Circuit Knowledge of Foreign Patent Laws: The Federal Circuit has now had what it styles as joint “en banc” sittings in Tokyo and elsewhere that manifest the understanding of the American judiciary’s knowledge of foreign patent laws and practices. Yet, a majority opinion has stated that “[p]atents and the laws that govern them are often described as complex. Indeed, one of the reasons cited for why Congress established our court was because it ‘felt that most judges didn't understand the patent system and how it worked.’ [citation omitted] As such *** the foreign sovereigns at issue in this case have established specific judges, resources, and procedures to ‘help assure the integrity and consistency of the application of their patent laws.’ Therefore, exercising jurisdiction over such subject matter could disrupt their foreign procedures.” Voda v.
    [Show full text]